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AnnotationThe beneﬁts of using ontology subsets versus full ontologies are well-documented for many applications.
In this study, we propose an efﬁcient subset extraction approach for a domain using a biomedical ontol-
ogy repository with mappings, a cross-ontology, and a source subset from a related domain. As a case
study, we extracted a subset of drugs from RxNorm using the UMLS Metathesaurus, the NDF-RT cross-
ontology, and the CORE problem list subset of SNOMED CT. The extracted subset, which we termed
RxNorm/CORE, was 4% the size of the full RxNorm (0.4% when considering ingredients only). For evalu-
ation, we used CORE and RxNorm/CORE as thesauri for the annotation of clinical documents and com-
pared their performance to that of their respective full ontologies (i.e., SNOMED CT and RxNorm). The
wide range in recall of both CORE (29–69%) and RxNorm/CORE (21–35%) suggests that more quantitative
research is needed to assess the beneﬁts of using ontology subsets as thesauri in annotation applications.
Our approach to subset extraction, however, opens a door to help create other types of clinically useful
domain speciﬁc subsets and acts as an alternative in scenarios where well-established subset extraction
techniques might suffer from difﬁculties or cannot be applied.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Biomedical ontologies are key to medical informatics, but their
size and complexity still represent a challenge in many applica-
tions [1]. The Systematized Nomenclature of Medicine-Clinical
Terms (SNOMED CT) [2], for example, comprises over a million
terms (text strings) structured as a taxonomy of 400,000 concepts
and an ontological layer that conforms to the EL þ þ description
logic standard [3]. Finding a portion of interest that can be used
as a virtual substitute for a whole ontology for a speciﬁc
application or domain is a highly desired objective, because it
reduces complexity, improves maintenance, encourages reuse
and customization, and improves performance in applications
[4]. These portions of interest are referred to as subsets, modules,
or segments.
An application where ontology subsets can play a major role is
in the annotation of clinical documents. A key part of the annota-
tion process consists of syntactically identifying ontology concepts
in the free text of the document by using efﬁcient string matching
techniques and a reference thesaurus [5]. This strategy is followed,for example, by the National Center for Biomedical Ontology
(NCBO) Annotator [6]. The content and size of the thesaurus play
a key role in the annotation process, inﬂuencing which and how
fast ontology concepts will be identiﬁed in free text.
The characteristics of the thesaurus are even more relevant in
the case of annotators that use ontology matching and word-sense
disambiguation techniques [7,8], such as MetaMap [9]. MetaMap
can produce more accurate results than efﬁcient string matching,
but it is computationally much more expensive: Aronson and Lang
showed that MetaMap can take up to a minute to process an aver-
age MEDLINE citation. Furthermore, they showed that some com-
plex phrases can require hours of computation when using the 5
million terms from the Uniﬁed Medical Language System (UMLS)
Metathesaurus [10] as a reference thesaurus, because hundreds
of thousands of potential mappings are generated [9].
Several approaches for extracting compact subsets from ontolo-
gies that might be used as a thesaurus for annotation have been
proposed. Research on ontology modularization, interested in
modules that preserve the logical entailments that can be derived
from the original ontology, has found efﬁcient strategies of extrac-
tion by traversing an ontology from a set of input key concepts, or
signature [4]. Ontology modularization techniques include graph-
traversal [11–14] and logic-based techniques [15,16], whose
extraction strategies depend on the ontology’s topology and its
deﬁnitional axioms, respectively. The requirement of preserving
1 UMLS Metathesaurus 2010AB Release, http://www.nlm.nih.gov/pubs/techbull/
nd10/nd10_umls.html.
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however, adds a large number of terms to the module that are un-
likely to be found in clinical documents, necessarily affecting pre-
cision and performance [17].
Therefore, term-frequency analysis of large corpora or datasets
is often preferred to produce small and precise subsets for annota-
tion [18–20]. One of the most relevant examples of such a subset is
the CORE problem list subset of SNOMED CT (CORE) [20], which is
only 1.50% the size of SNOMED CT but covers over 90% of the diag-
noses and problem lists found in existing reference datasets. Public
authoritative medical corpora are very scarce (with the notable
exception of the Multiparameter Intelligent Monitoring in Inten-
sive Care II clinical database [21]), and using a generalist corpus
(e.g., MEDLINE) might not provide good enough results because
of potential mismatch between content and vocabulary used in sci-
entiﬁc abstracts and clinical jargon [17]. To extract the CORE sub-
set, seven large-scale health care institutions collaborated to
analyze their datasets. It is expected that extracting a subset with
similar characteristics as CORE for a different domain would re-
quire a comparable effort, which is unfeasible in many cases.
Furthermore, in some scenarios only terms from one or more
speciﬁc domains might need to be identiﬁed in a medical docu-
ment. Pharmacovigilance using clinical notes [22] and extraction
of drug-disease treatment pairs from biomedical literature [23]
are two representative examples. In these cases, using a thesaurus
the size of the UMLS Metathesaurus or SNOMED CT imposes
unnecesary overhead when annotating because only drugs and dis-
eases are relevant in the free text. Domain-speciﬁc ontologies
might be preferred or even required when annotating. In the Uni-
ted States, for example, SNOMED CT is the designated standard ter-
minology for diagnoses and problem lists, but RxNorm is the
standardized nomenclature for clinical drugs for use in federal gov-
ernment systems [24].
The already available CORE problem list subset of SNOMED CT
represents a useful resource to annotate diseases, providing high
recall while being exceptionally compact in comparison to
SNOMED CT [20]. To the knowledge of the authors, no comparable
subset of RxNorm is available to annotate drugs.
Burton et al. [25], however, showed that the National Drug File-
Reference Terminology (NDF-RT) [26], a drug information source
produced by the U.S. Department of Veteran Affairs, was extremely
valuable for making inferences between medications and indica-
tions, because NDF-RT has comprehensive information on recom-
mended treatments [27].
NDF-RT, SNOMED CT, and RxNorm are all included in the UMLS
Metathesaurus [10], a biomedical ontology repository with map-
pings developed by the U.S. National Library of Medicine. Ontology
mappings are links between concepts from different ontologies
that are considered semantically equivalent and are the main ﬁeld
of study of ontology alignment or ontology matching [7]. The UMLS
Metathesaurus not only contains NDF-RT, SNOMED CT, and
RxNorm, but also mappings between them.
In this study, we explore the possibility of using mappings and
cross-ontologies available in ontology repositories as an efﬁcient
way to extract compact subsets for annotation, given the fact that
extremely compact high quality subsets such as CORE are already
available. In particular, the aims of the present work are as follows.
1.1. Objectives
1. To propose an approach that extracts a target subset TS from a
target domain ontology TO, using an existing, related source
subset SS from a related source domain ontology SO. The
approach uses a standard ontology repository, a cross-ontology
linking SO and TO, and mappings, and requires no preexisting
corpus or signature selection.2. To study and compare the relative size and performance of the
subsets SS and TS when used to annotate terms in clinical
documents, as opposed to using their full domain ontologies
SO and TO.
As a use case for evaluation, we extract a subset from RxNorm
(TO) in the domain of drugs for treatment, which we term
RxNorm/CORE (TS), using the existing CORE subset (SS) of SNOMED
CT (SO) in the domain of diseases. We use the NDF-RT ontology as a
link between SO and TO, and the UMLS Metathesaurus as an ontol-
ogy repository that provides the ontologies and mappings between
them. Finally, we study and compare the performance of RxNorm/
CORE and CORE for identifying terms mentioned in medical
research literature and discharge summaries.2. Materials and methods
Fig. 1 shows an overview of our approach to obtain the RNorm/
CORE subset, using the CORE problem list subset of SNOMED CT as
source. The following subsections describe the approach in depth.2.1. Materials
The Uniﬁed Medical Language System (UMLS) Metathesaurus
[10] is a knowledge base that comprises over 160 biomedical
ontologies (source vocabularies in UMLS terminology), including
SNOMED CT, NDF-RT, and RxNorm. The UMLS Metathesaurus is
part of the Uniﬁed Medical Language System, developed by the
U.S. National Library of Medicine to facilitate interoperability be-
tween computer systems [28].
Terms that represent the same concept (e.g., ‘heart attack’,
‘myocardial infarction’, ‘cardiac infarction’, or ‘infarction of heart’)
are assigned the same Concept Unique Identiﬁer (CUI) in the UMLS
Metathesaurus, regardless of which biomedical ontology they be-
long to. CUIs provide consistency for concepts and terms across
ontologies, facilitating interoperability. The UMLS 2010AB release1
was installed in a local MySQL database using MetamorphoSys, the
UMLS installation and customization program. The UMLS Metathe-
saurus, comprising 158 source vocabularies in its 2010AB release,
was accessed through standard SQL queries.
As an authoritative source subset for diseases, we selected the
CORE problem list subset of SNOMED CT. The CORE subset is a sub-
set containing 5814 concepts for documentation and encoding of
clinical information at a summary level. The concepts included in
the CORE subset represent the most frequently used terms in a ser-
ies of datasets submitted by seven large-scale health care institu-
tions that cover most medical specialties. The CORE subset
provides a recall above 90% for diagnoses and problem lists with
only 1.50% of the size of the full SNOMED CT [20]. Table 1 shows
the ﬁve concepts in the CORE subset that were most frequently
found in the submitted datasets.
Although the CORE subset is not part of the UMLS Metathesau-
rus, it is available online under the UMLS license. To maintain con-
sistency, we used the 201102 version derived from UMLS
Metathesaurus version 2010AB, which was the version of UMLS
used throughout the study.
We selected the NDF-RT ontology to serve as the linking compo-
nent. NDF-RT contains approximately 147,000 terms that repre-
sent 44,000 concepts, and it links our target and source domains
(i.e., drugs and diseases). We were only interested in drugs used
for treatment and we therefore used the relationship labeled as
‘may treat’. The ‘may treat’ relationship indicates that ‘‘medication
Fig. 1. Steps followed to obtain drugs in RxNorm related to diseases in the SNOMED CT CORE subset, using NDF-RT and the UMLS Metathesaurus. We term the target subset
RxNorm/CORE.
Table 1
The most frequent concepts in the CORE problem list subset of SNOMED CT.
Concept ID Preferred term Usage (%)
38341003 Hypertensive disorder, systemic arterial 3.09
55822004 Hyperlipidemia 1.90
35489007 Depressive disorder 1.52
268565007 Adult health examination 1.37
235595009 Gastroesophageal reﬂux disease 1.23
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toms, or closely associated diseases’’ [26]. The remaining three
relationships in NDF-RT that link both domains (‘may prevent’,
‘may diagnose’ and ‘induces’) were not used in this study.
Our target ontology was RxNorm, which is the standardized
nomenclature for clinical drugs for use in U.S. federal government
systems and which contains 437,000 terms that represent 194,000
concepts. The semantic approach used throughout the study fol-
lows the UMLS schema whereby two terms from the same or dif-
ferent ontologies were considered semantically equivalent if they
shared the same CUI in the UMLS Metathesaurus.
2.2. Methods
The ﬁve steps that we followed to obtain the drugs in RxNorm
related to diseases listed in the CORE subset using the UMLS Meta-
thesaurus were as follows (see Fig. 1):
1. UMLS CUIs of diseases from the CORE subset were ﬁrst
identiﬁed.
2. Drug-disease pairs using the ‘may treat’ relationships in
NDF-RT were extracted.
3. Identiﬁed NDF-RT diseases from step 2 were matched
against CORE diseases from step 1.
4. Matching diseases identiﬁed at step 3 were used as a signa-
ture to follow ‘may treat’ relationships in NDF-RT and ﬁnd
related drugs.
5. Identiﬁed drugs in NDF-RT were ﬁnally matched against
RxNorm.
The target subset, which we term RxNorm/CORE, consisted of
drugs in RxNorm used to treat diseases in the CORE subset, as sta-
ted in the NDF-RT linking ontology.
2.3. Evaluation
Xu et al. [19] described a ﬁltering approach to identify relevant
concepts in UMLS by studying howmany times each UMLS concept
appeared in an external corpus, with encouraging results. A subse-
quent study conﬁrmed the good results for SNOMED CT and
showed that a ﬁltering threshold higher than one (i.e., a concept
is relevant if it appears at least twice in a document) severely af-
fects precision and recall but only provides a marginal size reduc-tion [17]. Therefore, in this study we considered a concept relevant
for a corpus C if it appeared in at least one document of C. To mea-
sure the performance of a subset S (extracted from a domain ontol-
ogy O) to annotate a corpus C, we deﬁne the relative size, precision,
and recall of S as follows:
 RelativeSizeðS;OÞ ¼ jConceptsðSÞjjConceptsðOÞj
 RelativePrecisionðS;O;CÞ ¼ jRelevantConceptsðO;CÞ\ConceptsðSÞjjConceptsðSÞj
 RelativeRecallðS;O;CÞ ¼ jRelevantConceptsðO;CÞ\ConceptsðSÞjjRelevantConceptsðO;CÞj
For evaluation, we chose the following three heterogeneous
corpora as annotation scenarios:
1. A subset of 200,000 records from MEDLINE, containing
human case reportswritten in English from2005 to 2010 [17].
2. The 27,000 discharge summaries available in the Multipa-
rameter Intelligent Monitoring in Intensive Care II Research
Database (MIMIC-II), which contained reasons for admis-
sion and previous conditions in the domain of diseases, as
well as allergies, past medications, and indicated medica-
tions in the domain of drugs. The MIMIC-II database is a
large collection of de-identiﬁed data from the Intensive
Care Unit of Beth Israel Deaconess Medical Center offered
to the research community [21].
3. A data set of 600 de-identiﬁed discharge summaries from
Partners Healthcare, offered for the 2008 Natural Language
Processing obesity challenge (NLP-O), that contains similar
information to the one present in MIMIC-II [29].
Following the methodology described in López-García et al. [17]
we built ranked versions of the domain ontologies (SNOMED CT
and RxNorm), after storing the documents in the Lucene indexing
engine. With this approach, all strings are normalized and exact
string matching is used to match terms.
Three scores were added to each concept (MEDLINE, MIMIC-II,
and NLP-O), representing the number of documents from each
corpus where the concept had been identiﬁed (either in the title
or abstract in the case of MEDLINE, and anywhere in the docu-
ment in the case of the discharge summaries in MIMIC-II and
NLP-O).
Our goal was to analyze the efﬁcacy of using subsets for anno-
tation and, more speciﬁcally, to determine if our method extracted
a target subset (RxNorm/CORE) with similar efﬁcacy to that of the
source subset (i.e., CORE). Therefore, size, precision, and recall were
calculated for both RxNorm/CORE and CORE itself, relative to their
domain ontologies (i.e., RxNorm for RxNorm/CORE, and SNOMED
CT for CORE). Because SNOMED CT is a comprehensive, multi-do-
main ontology, we did not use the full SNOMED CT as the reference
domain ontology in our calculations when evaluating the CORE
subset. Instead, we used the clinical ﬁndings and diseases hierar-
chies. Moreover, because we were only interested in relative efﬁ-
cacy (i.e., what is missing when using a subset for annotation
Table 2
Distribution of concepts in the RxNorm/CORE subset, according to RxNorm term
types.
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about the absolute precision and recall of the full domain ontolo-
gies for annotating.Term type CUIs (%)
Semantic Clinical Drug (SCD) 74.80
Ingredient (IN) 13.73
Precise Ingredient (PIN) 6.50
Semantic Branded Drug (SBD) 4.51
Designated Synonym (SY) <1
Semantic Clinical Drug and Form (SCDF) <1
Generic Drug Delivery Device (GPCK) <1
Fully-speciﬁed drug Brand Name that cannot be prescribed (BN) <1
Name for a Multi-Ingredient (MIN) <13. Results
Using the CORE subset’s 5814 SNOMED CT concepts as input,
we were able to extract a subset of 7499 related current drugs in
RxNorm via NDF-RT’s ‘may treat’ relationships and mappings in
the UMLS Metathesaurus. Detailed results on the process, an anal-
ysis of CORE and the resulting RxNorm/CORE subset, and their per-
formance in terms of relative size, precision, and recall are
provided in the following subsections.3.1. Obtaining the RxNorm/CORE subset
Fig. 2 summarizes the number of CUIs involved in each of the
steps described in the Materials and Methods section.
1. The 5814 concepts in the CORE subset mapped to 5735
CUIs in UMLS.
2. Exactly 43,734 drug-disease pairs were identiﬁed in
NDF-RT, which mapped to 34,930 CUI pairs in UMLS. 937
diseases, and 8400 drugs were involved.
3. From the previous 937 diseases, 553 were present in the
CORE subset.
4. The previous 553 diseases were linked to 7755 drugs in
NDF-RT via ‘may treat’ relationships.
5. The resulting 7755 NDF-RT drugs mapped to 7499 drugs in
RxNorm.
3.2. The CORE subset, SNOMED CT, and UMLS
As shown in Fig. 2, the CORE subset’s 5814 concepts mapped to
5735 UMLS CUIs (see Fig. 2). There was a direct one-to-one map-
ping between SNOMED CT IDs and UMLS CUIs for the large major-
ity of concepts (97%). However, 51 UMLS CUIs mapped to 102
SNOMED CT concepts representing both a current and a concept
to be replaced, the latter marked as to be retired from the subset.
In 28 cases, two concepts with different SNOMED CT IDs (e.g.,
‘Alcohol dependence’ (ID 66590003) and ‘Persistent alcohol abuse’
(ID 284591009)) mapped to the same UMLS CUI (C0001973). In
SNOMED CT, concepts in the diseases sub-hierarchy (ID
64572001, 63,884 concepts) represent 66% of the concepts in the
clinical ﬁndings (ID 404684003, 96,783 concepts) hierarchy. In
CORE, this ﬁgure increases to 83%, with 4133 diseases out of a total
of 4968 clinical ﬁndings.Fig. 2. UMLS CUIs involved when extracting drugs in RxNorm relat3.3. The RxNorm/CORE subset
The extracted RxNorm/CORE subset of 7449 concepts was 3.87%
the size of the full RxNorm in terms of UMLS CUIs. The distribution
of concepts according to RxNorm term types is shown in Table 2.
As displayed in Table 2, the majority of concepts in RxNorm/
CORE corresponded to Semantic Clinical Drugs, which represent
an ingredient plus strength and dose form. It must be noted, how-
ever, that all ingredients in Semantic Clinical Drugs are also pres-
ent in RxNorm/CORE independently, because the ‘may treat’
relationship from NDF-RT links the diseases to indications in the
form of ingredients as well. As an example, Table 3 shows an ex-
tract of the recommended treatments for edema (UMLS CUI
C0013604), as captured by the ‘may treat’ relationship in NDF-
RT. When considering only ingredients in RxNorm/CORE, the rela-
tive size of the subset is reduced to 0.4%.3.4. Evaluation
The top part of Table 4 shows the relative size of RxNorm/CORE,
and its performance in terms of precision and recall when used to
annotate the MEDLINE, MIMIC-II, and NLP-O corpora. The size and
performance were measured with respect to the domain ontology
from which RxNorm/CORE was extracted (RxNorm). In the case of
CORE, we used the diseases and clinical ﬁndings hierarchies of
SNOMED CT (see Section 2.3).
The recall of RxNorm/CORE was below 35% for all corpora,
although it was more compact with respect to its domain ontology.
RxNorm/CORE showed better performance when used to annotate
records from MEDLINE (34.79%) than discharge summaries from
MIMIC-II (20.53%) and NLP-O (31.32%), the opposite of CORE.
Fig. 3 provides a direct comparison between the SNOMED CT CORE
subset and RxNorm/CORE with respect to their reference ontolo-
gies and domains for each corpus. The precision of CORE was sig-
niﬁcantly higher in all cases.ed to diseases in the CORE problem list subset of SNOMED CT.
Table 5






Fig. 3. Recall comparison between the SNOMED CT CORE subset and RxNorm/CORE
with respect to their reference ontologies.
Table 4
Performance of RxNorm/CORE and CORE to annotate the selected corpora. The size
and performance were measured with respect to their reference ontologies (RxNorm
for RxNorm/CORE and SNOMED CT clinical ﬁndings/diseases branches for CORE).
Subset (reference ontology) MEDLINE (%) MIMIC-II (%) NLP-O (%)
RxNorm/CORE (RxNorm)
Relative size: 3.87%
Precision 14.83 11.79 5.67
Recall 34.79 20.53 31.32
CORE (SNOMED CT diseases)
Relative size: 9.10%
Precision 31.06 25.95 9.22
Recall 28.60 40.84 69.34
CORE (SNOMED CT clinical ﬁndings)
Relative size: 6.01%
Precision 37.62 31.53 12.35
Recall 24.42 32.51 53.03
Table 3
Extract of recommended treatments for edema, as captured by the ‘may treat’
relationship in NDF-RT.
Term Term type CUI
Torsemide IN C0076840
Torsemide 10 MG Oral Tablet SCD C0690835
Torsemide 10 MG/ML Injectable Solution SCD C0499011
Torsemide 100 MG Oral Tablet SCD C0690836
Torsemide 20 MG Oral Tablet SCD C0690837
Torsemide 5 MG Oral Tablet SCD C0690838
Triamterene IN C0040869
Triamterene 100 MG Oral Capsule SCD C0690636
Triamterene 50 MG Oral Capsule SCD C0690637
Trichlormethiazide IN C0040899
Trichlormethiazide 2 MG Oral Tablet SCD C0703753
Trichlormethiazide 4 MG Oral Tablet SCD C0690644
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size of the domain ontology and subsets, and the number of rele-
vant concepts found are shown in Tables 5–7.4. Discussion
Prior work has documented the effectiveness of using cross-
ontologies and mappings to infer relevant concepts from related
domains, as is the case with NDF-RT for drugs and diseases [25].
Our case study described a similar approach to obtain a compact
subset of drugs from RxNorm (roughly 4% its size, 0.4% when con-
sidering ingredients only) using the CORE subset of SNOMED CT as
source and the UMLS Metathesaurus to provide the mappings,
which are both available to the biomedical informatics research
community. Other available drug-indications linking components
are the Medi-Span (Wolters Kluwer Health, Indianapolis) Drug-
Indications Database,2 and the following ones identiﬁed by Névéol
and Lu [30]: MeSH,3 DailyMed,4 DrugBank,5 and AHFS Consumer
Medication Information.6 These linking components, however, are
not available in the UMLS Metathesaurus.
We followed Burton et al.’s approach based on their encourag-
ing results and the accuracy of mappings between NDF-RT and
RxNorm in the UMLS Metathesaurus [25]. However, our case study
revealed that by using only direct mappings to infer related con-
cepts from different ontologies, important information might be
missed in some cases. Using UMLS CUIs, we were only able to di-
rectly map 553 (roughly 10%) of the diseases in the CORE subset
to diseases in NDF-RT for which recommended treatment informa-
tion existed. The most plausible explanation for this mismatch, in
good agreement with Burton et al. [25], is that diseases in NDF-
RT map to SNOMED CT terms that are more general than the ones
found in problem lists, such as the CORE subset we used as a sig-
nature for the inferences. Problems when matching diseases be-
tween CORE and NDF-RT suggest that simple CUI matching
between ontologies might not be an acceptable alternative in many
cases, such as when the granularity of ontologies or of term usage
is different. We also identiﬁed 28 cases in the CORE subset where
two concepts with different SNOMED CT IDs mapped to the same
UMLS CUI, which can be regarded as a semantic mismatch that
should be taken into account when working with CUIs.
The limited precision and recall of RxNorm/CORE (Table 4) to
annotate clinical documents conﬁrms that extracting subsets for
annotation is particularly challenging and that frequency-based
techniques that use a clinical corpus close to the application are
preferred if available [18,17]. In our case study, the performance
of RxNorm/CORE to annotate drugs with respect to RxNorm was
slightly better than using CORE to annotate diseases with respect
to the diseases and clinical ﬁnding hierarchies of SNOMED CT in
the case of MEDLINE. It must be noted that CORE is derived from
clinical data, so it was expected to perform better in clinical cor-
pora. Another issue that should be considered is the nature of
the RxNorm/CORE subset that we extracted. Semantic Clinical Drug
comprises the majority of the subset, but the size of the subset can
be reduced an order of magnitude if only ingredients are to be
identiﬁed in clinical documents, dramatically improving precision
without sacriﬁcing recall.
The qualitative beneﬁts of using ontology subsets versus full
ontologies in applications are many, and they are well-docu-
mented (complexity reduction, maintenance improvement, easy






The number of concepts in each domain ontology and subset.




SNOMED CT diseases 63,884
SNOMED CT clinical ﬁndings 96,783
Table 7
Relevant concepts for each domain ontology and subset in the selected corpora. A
concept was considered relevant if it appeared in at least one document of the corpus.
Domain Ontology or subset MEDLINE MIMIC-II NLP-O
Drugs RxNorm/CORE 1112 884 425
RxNorm 3196 4306 1357
Diseases CORE diseases 1806 1509 536
CORE clinical ﬁndings 2187 1833 718
SNOMED CT diseases 6315 3695 773
SNOMED CT clinical ﬁndings 8957 5638 1354
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ments suggest that the beneﬁts of using ontology subsets as the-
sauri in annotation applications should be reassessed.
5. Conclusions and future work
In this study, we have shown that cross-ontologies and bio-
medical ontology repositories with mappings are valuable tools
to extract an ontology subset efﬁciently when another subset
from a related domain is already available. In our case study,
we used ontology subsets to serve as a reference thesaurus for
annotating diseases and drugs in clinical documents. The CORE
subset of SNOMED CT not only proved to be a useful resource to
annotate diseases, but it also served as an authoritative source
subset for extracting a related subset of drugs of RxNorm using
our approach.
Our approach to subset extraction opens a door to help create
other types of clinically useful domain-speciﬁc subsets, for exam-
ple, in the domain of anatomy by using CORE as the source subset
and the ‘ﬁnding site’ relationship that links diseases and anatomi-
cal sites in SNOMED CT. In this case, target ontologies of interest
could be the SNOMED CT anatomy branch or the Foundational
Model of Anatomy (FMA) [31], although mappings between
SNOMED CT and FMA are not yet available in the UMLS
Metathesaurus.
Our approach also acts as an alternative in scenarios where
well-established subset extraction techniques might suffer from
difﬁculties. This is the case for term frequency analysis when a local
corpus related to the domain is not available or is not representa-
tive enough, and for ontology modularization techniques when
they are not capable of working with multiple ontologies or there
is uncertainty regardingwhich concepts to use as an input signature.
The analysis of our results revealed several limitations in the
subset extraction process and opened new research questions to
be explored in future work, as follows:
1. Improving the mapping technique beyond mere CUI
matching by using the hierarchies of the ontologies to infer
concepts that are now not taken into account, to minimize
the impact of different granularity or term usage between
ontologies.
2. Using other drug-indications linking components, such as
the ones identiﬁed by Névéol and Lu [30].3. Exploring our strategy in open biomedical ontology
repositories such as BioPortal [32]. Open biomedical ontol-
ogy repositories constitute a new opportunity to reuse
domain-speciﬁc subsets submitted by users.
4. Quantitatively analyzing the performance gain (e.g., speed
and memory usage) when using ontology subsets instead
of full ontologies as thesauri in annotation applications.
Finally, this study adds to the existing studies suggesting that
there is no universal way to extract subsets from ontologies and
that the task of subset extraction should be strongly guided by
each particular domain and application [14]. Furthermore, not only
is the adequate technique essential to optimize the efﬁcacy of the
subsets, but also the data used for input and validation. More cor-
pora of discharge summaries available to the health informatics
community, which are still scarce, would also be especially wel-
come to generalize the results of this study to other domains and
applications.
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